Archives
-
MOMP mRNA Vaccine Protects Mice Against C. psittaci
2026-09-26
A lipid nanoparticle (LNP)-delivered mRNA vaccine encoding the major outer membrane protein (MOMP) of Chlamydia psittaci induced humoral and cellular immune responses in BALB/c mice. The study reports reduced pulmonary pathogen burden and inflammatory cytokine levels, providing preclinical evidence for an mRNA-vaccine approach while leaving important formulation and dosing questions for further work.
-
EZ Cap™ Firefly Luciferase mRNA for LNP Assays
2026-09-25
Use this capped luciferase transcript to compare how delivery conditions affect functional mRNA expression—not merely particle uptake. A practical workflow connects cell-based optimization with the live-animal lymph-node imaging strategy reported by Misra and colleagues, while keeping reporter signal and nanoparticle distribution distinct.
-
BoNT/A, SOCS3, and Ocular Angiogenesis
2026-09-25
In a mouse model of laser-induced choroidal neovascularization, intravitreal botulinum neurotoxin A reduced lesion burden and vascular leakage alongside lower glial activation and VEGFA expression. SOCS3-deficient experiments indicate that neuronal/glial SOCS3 contributes to this protection, suggesting a glia-linked avenue for studying pathological ocular angiogenesis—not a demonstrated replacement for anti-VEGF therapy.
-
Cy5 NHS ester(Et): Practical Labeling Guide
2026-09-24
Cy5 NHS ester(Et) provides a way to attach a Cy5 fluorescent label to primary amines in proteins, peptides, and other biomolecules for detection or imaging workflows. It is suited to freshly prepared labeling reactions, but not to ethanol-based preparation or long-term storage of reagent solutions.
-
Qushi Huoxue Ointment in MASLD
2026-09-24
A 2026 mouse study reports that Qushi Huoxue ointment reduced hepatic lipid deposition and inflammatory injury in a diet-induced MASLD model, alongside changes consistent with greater autophagy and less ferroptosis. The integrated molecular and ultrastructural analyses suggest a coordinated mechanism, while the study design leaves important questions about pathway causality and relevance to human disease unresolved.
-
Annexin V-Cy5 Apoptosis Kit in Microglia Research
2026-09-23
The Annexin V-Cy5 Apoptosis Kit provides a rapid way to assess phosphatidylserine exposure when studying cell-death responses alongside microglial lysosomal stress. Use it as a complementary readout—not a substitute for lysosomal-function assays—to test whether a stress phenotype involves apoptosis.
-
Cy5-UTP for RNA Probe Synthesis and Imaging
2026-09-23
Cy5-UTP enables direct, far-red visualization of RNA produced by T7 in vitro transcription, reducing dependence on post-synthesis staining. This guide connects practical RNA probe synthesis, FISH, and dual-color assay design with a cautious workflow for tracking labeled mRNA in lipid nanoparticle studies.
-
HA-LNP PTEN mRNA for Transdermal Melanoma Therapy
2026-09-22
This study develops a hyaluronate-conjugated lipid nanoparticle that uses HA-DMG to combine particle stabilization, skin penetration, and CD44-directed uptake for topical PTEN mRNA delivery. In melanoma models, the platform restored PTEN expression, promoted immunogenic cell death, activated antitumor immunity, and suppressed tumor growth with limited observed toxicity.
-
Zosuquidar (LY335979): A Transporter-Aware MDR Guide
2026-09-22
Zosuquidar (LY335979) is examined here through a transporter-aware lens that connects P-gp inhibition with pharmacokinetic variability. Learn how disease-state biology, orthogonal assays, and careful controls can improve studies of multidrug resistance in cancer.
-
Targeted mRNA Nanoparticles in Ischemic Stroke
2026-09-21
Gao and colleagues developed mannose-targeted lipid nanoparticles carrying IL-10 mRNA to promote protective microglial polarization after ischemic stroke. In mouse models, this strategy reduced neuroinflammation, improved blood–brain barrier integrity, limited neuronal apoptosis, and alleviated neurological deficits, supporting targeted mRNA delivery as a potential poststroke intervention.
-
Microfluidic Peptide/RNA Complexes for Pulmonary Delivery
2026-09-21
Ma and colleagues developed cationic peptide/RNA complexes using microfluidic mixing and evaluated their stability during vibrating-mesh nebulisation. Both siRNA and mRNA formulations produced inhalable aerosols and retained RNA binding and in vitro transfection performance after aerosolisation, supporting further pulmonary delivery system research.
-
HyperScript™ IV RT SuperMix: RT-qPCR Guide
2026-09-20
HyperScript™ IV RT SuperMix for qPCR (with gDNA wiper) is a K1590 reverse-transcription quantitative PCR reagent for converting RNA into measurable cDNA signals. The referenced Magnaporthe oryzae study provides biological targets and benchmarks for expression analysis, but it does not establish product-specific performance.
-
Cy5-UTP: Reliable RNA Labeling for Cell Assays
2026-09-19
Learn how Cy5-UTP (Cyanine 5-UTP), SKU B8333, can add a defined RNA-level readout to cell viability, proliferation, and cytotoxicity workflows without being mistaken for a direct viability reagent. This scenario-based guide covers probe synthesis, fluorescence interpretation, storage, compatibility, and practical vendor selection.
-
EZ Cap™ Cas12a mRNA: Reading Editing Outcomes
2026-09-18
Discover how EZ Cap™ CPF1/Cas12a mRNA (m1Ψ) can be evaluated as a transient Cas12a expression component by connecting PAM geometry, staggered cleavage, repair outcomes, and assay design. This article adds a mechanistic interpretation framework beyond routine workflow guidance.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-18
Separate mRNA delivery from protein expression with one fluorescent reporter designed for mammalian-cell assays. This workflow shows how to use Cy5 tracking, EGFP translation, and modified nucleotides to compare delivery systems and troubleshoot inconsistent results.